Cargando…

Synthesis, isolation and purification of [(11)C]-choline

[(11)C]-choline is an effective PET tracer used for imaging of neoplastic lesions and metastases of the prostate cancer. However, its production can be a challenge for manufacturers, as it has not yet been described in Polish or European pharmacopoeia. In this study the technical aspects of [(11)C]-...

Descripción completa

Detalles Bibliográficos
Autores principales: Szydło, Marcin, Jadwiński, Michał, Chmura, Agnieszka, Gorczewski, Kamil, Sokół, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013686/
https://www.ncbi.nlm.nih.gov/pubmed/27660552
http://dx.doi.org/10.5114/wo.2016.61566
_version_ 1782452215911284736
author Szydło, Marcin
Jadwiński, Michał
Chmura, Agnieszka
Gorczewski, Kamil
Sokół, Maria
author_facet Szydło, Marcin
Jadwiński, Michał
Chmura, Agnieszka
Gorczewski, Kamil
Sokół, Maria
author_sort Szydło, Marcin
collection PubMed
description [(11)C]-choline is an effective PET tracer used for imaging of neoplastic lesions and metastases of the prostate cancer. However, its production can be a challenge for manufacturers, as it has not yet been described in Polish or European pharmacopoeia. In this study the technical aspects of [(11)C]-choline production are described and detailed process parameters are provided. The quality control procedures for releasing [(11)C]-choline as solutio iniectabilis are also presented. The purity and quality of the radiopharmaceutical obtained according to the proposed method were find to be high enough to safely administrate the radiopharmaceutical to patients. Application of an automated synthesizer makes it possible to carry out the entire process of [(11)C]-choline production, isolation and purification within 20 minutes. It is crucial to maintain all aspects of the process as short as possible, since the decay half-time of carbon-11 is 20.4 minutes. The resulting radiopharmaceutical is sterile and pyrogen-free and of a high chemical, radiochemical, and radionuclide purity proved by chromatographic techniques. The yield of the process is up to 20%. [(11)C]-choline PET scanning can be used as accurate and effective diagnostic tool in all centers equipped with [(11)C]-target containing cyclotron.
format Online
Article
Text
id pubmed-5013686
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-50136862016-09-22 Synthesis, isolation and purification of [(11)C]-choline Szydło, Marcin Jadwiński, Michał Chmura, Agnieszka Gorczewski, Kamil Sokół, Maria Contemp Oncol (Pozn) Original Paper [(11)C]-choline is an effective PET tracer used for imaging of neoplastic lesions and metastases of the prostate cancer. However, its production can be a challenge for manufacturers, as it has not yet been described in Polish or European pharmacopoeia. In this study the technical aspects of [(11)C]-choline production are described and detailed process parameters are provided. The quality control procedures for releasing [(11)C]-choline as solutio iniectabilis are also presented. The purity and quality of the radiopharmaceutical obtained according to the proposed method were find to be high enough to safely administrate the radiopharmaceutical to patients. Application of an automated synthesizer makes it possible to carry out the entire process of [(11)C]-choline production, isolation and purification within 20 minutes. It is crucial to maintain all aspects of the process as short as possible, since the decay half-time of carbon-11 is 20.4 minutes. The resulting radiopharmaceutical is sterile and pyrogen-free and of a high chemical, radiochemical, and radionuclide purity proved by chromatographic techniques. The yield of the process is up to 20%. [(11)C]-choline PET scanning can be used as accurate and effective diagnostic tool in all centers equipped with [(11)C]-target containing cyclotron. Termedia Publishing House 2016-08-04 2016 /pmc/articles/PMC5013686/ /pubmed/27660552 http://dx.doi.org/10.5114/wo.2016.61566 Text en Copyright: © 2016 Termedia Sp. z o. o. http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
spellingShingle Original Paper
Szydło, Marcin
Jadwiński, Michał
Chmura, Agnieszka
Gorczewski, Kamil
Sokół, Maria
Synthesis, isolation and purification of [(11)C]-choline
title Synthesis, isolation and purification of [(11)C]-choline
title_full Synthesis, isolation and purification of [(11)C]-choline
title_fullStr Synthesis, isolation and purification of [(11)C]-choline
title_full_unstemmed Synthesis, isolation and purification of [(11)C]-choline
title_short Synthesis, isolation and purification of [(11)C]-choline
title_sort synthesis, isolation and purification of [(11)c]-choline
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013686/
https://www.ncbi.nlm.nih.gov/pubmed/27660552
http://dx.doi.org/10.5114/wo.2016.61566
work_keys_str_mv AT szydłomarcin synthesisisolationandpurificationof11ccholine
AT jadwinskimichał synthesisisolationandpurificationof11ccholine
AT chmuraagnieszka synthesisisolationandpurificationof11ccholine
AT gorczewskikamil synthesisisolationandpurificationof11ccholine
AT sokołmaria synthesisisolationandpurificationof11ccholine